| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Sook-Hyang Jeong | Q88677490 |
| P2093 | author name string | Kyung-Ah Kim | |
| P2860 | cites work | Colchicine for primary biliary cirrhosis | Q24247122 |
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Incidence of cancer in primary biliary cirrhosis: the Mayo experience | Q33601440 | ||
| Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis | Q33671978 | ||
| Farnesoid X receptor agonists for primary biliary cirrhosis | Q34162898 | ||
| Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? | Q34190802 | ||
| SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS | Q34259351 | ||
| Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. | Q34328076 | ||
| Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. | Q34330984 | ||
| Characterisation of patients with a complete biochemical response to ursodeoxycholic acid | Q34408204 | ||
| Serum bilirubin: a prognostic factor in primary biliary cirrhosis | Q34494336 | ||
| Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression | Q34734065 | ||
| Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years | Q34932835 | ||
| Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)? | Q35030826 | ||
| Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment | Q35358467 | ||
| Natural history of primary biliary cirrhosis. | Q35573903 | ||
| The epidemiology of primary biliary cirrhosis | Q35573904 | ||
| Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. | Q35596429 | ||
| Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort | Q35596580 | ||
| Presentation and diagnosis of primary biliary cirrhosis in the 21st century | Q37154295 | ||
| Multidrug resistance3 is in situ detected in the liver of patients with primary biliary cirrhosis, and induced in human hepatoma cells by bezafibrate. | Q40482690 | ||
| The true impact of fatigue in primary biliary cirrhosis: a population study | Q40643274 | ||
| Epidemiology and natural history of primary biliary cirrhosis in a US community | Q40735092 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| Natural history of early primary biliary cirrhosis | Q41234807 | ||
| Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver | Q41853347 | ||
| A prospective trial of colchicine for primary biliary cirrhosis | Q42659809 | ||
| Clinical features and prognosis of primary biliary cirrhosis in Korea | Q42981206 | ||
| Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis | Q43478375 | ||
| Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid | Q43483632 | ||
| Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients. | Q43734578 | ||
| Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial | Q43766090 | ||
| Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid | Q43893454 | ||
| Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis | Q44487597 | ||
| Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history | Q44606835 | ||
| Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients | Q44699692 | ||
| Natural history of pruritus in primary biliary cirrhosis | Q44797529 | ||
| Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis | Q44930578 | ||
| Tamoxifen: a novel treatment for primary biliary cirrhosis? | Q44930581 | ||
| Quality of life in patients with primary biliary cirrhosis | Q45059665 | ||
| Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid | Q45245096 | ||
| The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis | Q45247238 | ||
| Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid | Q46126105 | ||
| Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis | Q46408092 | ||
| Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis | Q46775425 | ||
| 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice | Q46939923 | ||
| Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence | Q48496394 | ||
| The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis | Q49110706 | ||
| Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. | Q50535528 | ||
| Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid | Q51636366 | ||
| Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. | Q54032405 | ||
| Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. | Q54118475 | ||
| Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid | Q55174800 | ||
| Primary biliary cirrhosis | Q56428273 | ||
| Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis | Q56994503 | ||
| Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis | Q57004434 | ||
| A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results | Q67590480 | ||
| Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study | Q68781360 | ||
| Trial of penicillamine in advanced primary biliary cirrhosis | Q69887093 | ||
| Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial | Q70542319 | ||
| Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis | Q71035932 | ||
| Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression | Q71949347 | ||
| Prediction of prognosis of primary biliary cirrhosis in Japan | Q72336290 | ||
| The natural history of abdominal pain associated with primary biliary cirrhosis | Q72760329 | ||
| Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study | Q73363202 | ||
| Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid | Q73401694 | ||
| Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver | Q73715566 | ||
| Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis | Q73979498 | ||
| Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group | Q77221662 | ||
| Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial | Q77872001 | ||
| Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial | Q78039888 | ||
| Liver transplantation for primary biliary cirrhosis | Q79240270 | ||
| Are esophagogastric varices a late manifestation in primary biliary cirrhosis? | Q79364878 | ||
| Natural history of primary biliary cirrhosis | Q81213642 | ||
| Primary biliary cirrhosis | Q81246142 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 173-179 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | The Korean journal of hepatology | Q27720798 |
| P1476 | title | The diagnosis and treatment of primary biliary cirrhosis | |
| P478 | volume | 17 |
| Q93047420 | Amyotrophic Lateral Sclerosis and Primary Biliary Cirrhosis Overlap Syndrome: Two Cases Report |
| Q45389459 | Concurrent Occurrence of Primary Biliary Cirrhosis and Rheumatoid Arthritis |
| Q64228080 | Detection of Autoantibodies Against Nucleoporin p62 in Sera of Patients With Primary Biliary Cholangitis |
| Q39542696 | Diagnostic accuracy of two tests for determination of anti-m2 in the diagnosis of primary biliary cirrhosis: Is it possible to predict the course of the disease? |
| Q37116528 | Johan Turi's animal, mineral, vegetable cures and healing practices: an in-depth analysis of Sami (Saami) folk healing one hundred years ago. |
| Q41531249 | New developments in the treatment of primary biliary cholangitis - role of obeticholic acid |
| Q64039446 | Regenerative Medicine of the Bile Duct: Beyond the Myth |
| Q34438127 | The association between bile salt export pump single-nucleotide polymorphisms and primary biliary cirrhosis susceptibility and ursodeoxycholic acid response |
Search more.